Drug Safety Alerts


2019 ACIP Immunization Schedule


Withdrawn: Zinbryta for Multiple Sclerosis


FDA Issues Warning on Risk of Anaphylaxis with Varubi® (Rolapitant)


FDA Approves Hydroxyurea for Treatment of Sickle Cell Disease in Children


FDA Approves Soliris® (eculizumab) for Myasthenia Gravis


FDA Approves Gocovri™ for Treatment of Dyskinesia in Parkinson’s Disease


FDA Approves First Generic Three-Times Weekly Formulation of Copaxone


FDA Approves New Uses for Two Antiseizure Drugs


Recall Notice: Mislabeled Amantadine HCl for Parkinson’s Disease


FDA Approves Subcutaneous Belimumab (Benlysta)


FDA Approves Endari for Sickle Cell Disease


GlaxoSmithKline Recalls Inhalers for Possible Package Leakage


FDA Approves Once-Daily Raltegravir


FDA: New Warnings for Diabetes Drug Canagliflozin


KOĀTE Factor Supply for Hemophilia A is Now Ready


FDA Drug Warning: Codeine and Tramadol


Nationwide Recall of EpiPen and EpiPen Jr